NMRA 250117 1.50C (NMRA250117C1500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

NMRA250117C1500

Watchlist

0.75
+0.05+7.14%

15min DelayClose Jan 3 16:00 ET

0.75High0.70Low

Intraday

5D
Daily

News

Trending Stocks as Wall Street Steps Into First Days of 2025 With Cautiousness
Seeking AlphaJan 4 12:09 ET
Sector Update: Health Care Stocks Higher Friday Afternoon
MT NewswiresJan 3 13:57 ET
Neumora Therapeutics Up Over 16%, on Pace for Largest Percent Increase Since December 2023 -- Data Talk
Dow JonesJan 3 11:05 ET
Neumora Has 2 More Chances With Navacaprant After Readout Miss, Mizuho Says
MT NewswiresJan 3 10:47 ET
Rivian Automotive, Cerence, Nu Skin Enterprises And Other Big Stocks Moving Higher On Friday
BenzingaJan 3 10:22 ET
J.P. Morgan Maintains Neumora Therapeutics(NMRA.US) With Hold Rating
Moomoo NewsJan 3 08:31 ET · Ratings

Comments

degree of freedom

Jan 3 10:29

Buy!

$Neumora Therapeutics (NMRA.US)$

Amp

Jan 3 10:26

Way oversold imo

$Neumora Therapeutics (NMRA.US)$

ExtremeInvest

Jan 3 09:18

Buy now and hold till 5 or higher, unrealistic?

$Neumora Therapeutics (NMRA.US)$
H.C. Wainwright reaffirmed its Buy rating and a price target of $30.00 for Neumora Therapeutics (NASDAQ:NMRA) stock.
——-
On Friday, Mizuho (NYSE:MFG) Securities reiterated its Outperform rating on Neumora Therapeutics (NASDAQ:NMRA) with a steady price target of $20.00, despite the company's recent setback with its lead drug candidate, navacaprant.
———-
jp morgan target price 15

ExtremeInvest

Jan 3 07:18

$Neumora Therapeutics (NMRA.US)$ target price $30.. time to buy before regret.

104925516

Jan 3 06:56

the selloff was indeed overdone imho

$Neumora Therapeutics (NMRA.US)$Neumora Therapeutics Selloff Seen as Overdone -- Market Talk
Many antidepressants have had at least one Phase 3 failure before winning approval